LataMed AI Corp.
LataMed AI Corp. is a U.S.-based healthcare technology company focused on artificial intelligence-enabled analytics, telehealth infrastructure, and healthcare services coordination. The company’s operating structure includes a wholly owned Venezuelan subsidiary intended to support its Latin American healthcare technology and services platform.
Tilikausi 2025 · muutos edellisvuodesta
Kehitys 2023–2025
Liiketoiminta
Osuus liikevaihdostaSoftware and data tools for healthcare analytics, monitoring, and decision support.
Technology used to support remote care delivery and virtual healthcare workflows.
Services that organize patient pathways, referrals, and healthcare service delivery.
Proprietary assets and intellectual property acquired for platform development.
Asiakkaat
The company appears to serve healthcare organizations and service providers that need software and operational tools for analytics, telehealth, and patient coordination. Its Latin America focus suggests customers may also include regional healthcare operators and partners seeking localized digital health infrastructure. Because the business is still in an early operating build-out phase, customer relationships are likely centered on platform adoption, pilot deployments, and business development rather than broad-scale recurring usage.
Hospitals, clinics, and care networks that would use analytics, monitoring, and telehealth tools to improve care delivery.
Organizations coordinating patient services and workflows that need software to manage care pathways and communications.
Regional operators and counterparties in Latin America that may adopt localized healthcare technology and services.
Customers needing virtual care infrastructure and related digital health applications.
Strategia
The company is transitioning toward an AI-enabled healthcare technology and services model centered on Latin America. Its near-term priorities appear to be integrating acquired healthcare technology assets, building operating infrastructure, and advancing regulatory and business development work needed to commercialize the platform. Financing remains a strategic requirement because the business is still in development and has not yet established a revenue base.
The company needs a marketable product and service offering to convert development work into revenue.
Regional execution depends on local operating entities, regulatory readiness, and market relationships.
The acquired IP and technology assets are the core inputs for the company’s platform strategy.
A development-stage healthcare technology business typically requires funding before scale is reached.
Maantiede
LataMed AI Corp. is incorporated in the United States, but its stated operating focus is Latin America. The company has also organized a Venezuelan subsidiary to serve as an operating entity and to support its broader regional strategy. This geographic mix creates exposure to cross-border execution, local regulatory requirements, and country-specific operating conditions in Latin America.
Riskit
The company faces early-stage execution and financing risk because it is still building its healthcare technology platform and has not yet established meaningful revenue. Its Latin America strategy adds regulatory, operational, and cross-border complexity, while the use of acquired intellectual property introduces integration and valuation risk. As with many development-stage software and healthcare services businesses, success depends on product adoption, capital access, and the ability to navigate healthcare-specific compliance requirements.
The company states it does not have sufficient cash to operate at the current level for the next twelve months.
Kohdistuu: Operations and platform development
The business is still in organizational development and has not generated revenue, so product-market fit is unproven.
Kohdistuu: Healthcare AI and telehealth offerings
Operating in Latin America, including Venezuela, can involve local healthcare, data, and corporate compliance requirements.
Kohdistuu: Regional expansion
The company acquired proprietary healthcare technology assets and must integrate them into its operating model.
Kohdistuu: Platform development and IP utilization
Kirjanpito
Harkinnanvaraiset erätHealthcare software and services contracts may include multiple obligations and timing judgments.
Vaikutus: Affects when and how contract revenue is recorded
The company acquired proprietary healthcare technology assets and IP that must be assessed for recoverability.
Vaikutus: Could create impairment charges if expected value is not realized
The company references ASC 820 and may need to estimate values for instruments or acquired assets.
Vaikutus: Can affect balance sheet carrying values and expense recognition
Equity awards, if used, require grant-date fair value measurement and expense recognition over time.
Vaikutus: Can materially increase reported operating expenses
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Optomed Oyj
OPTOMED · Health Information Services
Optomed is a Finnish health technology company specializing in handheld fundus cameras and screening software solutions.
Spectral AI, Inc.
MDAI · Surgical & Medical Instruments & Apparatus
Adapti, Inc.
ADTI · Services-Amusement & Recreation Services
VisionSys AI Inc
VSA · Services-Educational Services
VisionSys AI Inc is a U.S.-listed Cayman Islands holding company focused on brain-machine interaction technologies and AI-enabled software and hardware systems.
MedWellAI, Inc.
MWAI · Finance Services
CONMED Corp
CNMD · Electromedical & Electrotherapeutic Apparatus
CONMED Corp is a U.S.-based medical technology company focused on devices and equipment used in surgical procedures.
Päivitetty: 24.9.2026